The platform
United States
Outpatient theranostics centres in secondary metropolitan areas, co located with urology and medical oncology groups. Each holds its own radioactive materials licence and hot laboratory, and runs three service lines off one licence: radioligand therapy, PSMA imaging, and adjacent radionuclide therapies.
South Africa
Centres placed inside existing private hospital campuses under hosting agreements, so we rent capability into beds that already exist. Each carries a licensed compounding radiopharmacy and supplies Lu-177 PSMA I&T under section 21 rather than importing a branded product.
Both jurisdictions
Not a separate business. A capability layer that sells sponsors the one thing they cannot buy at scale anywhere: the ability to enrol radioligand therapy patients quickly, in sites that already hold the licences and already employ the physicists.
Aletheia is not a drug developer, not an isotope producer and not a hospital operator.